Skip to main content
. 2013 Sep 6;5(6):946–955. doi: 10.4161/mabs.26390

graphic file with name mabs-5-946-g3.jpg

Figure 3. Synergistic effects of two mAbs on HBV-neutralizing activity. (A) Quantification of HBsAg levels in the supernatant of HepaRG cells at 7 d after infection with HBV pretreated with C4G4, D2H2 and C4G4 plus D2H2. (B). Quantification of HBV-DNA in HepaRG cells at 7 d after infection with HBV pretreated with C4G4, D2H2 and C4G4 plus D2H2. Results were shown as mean ± SD of three independent experiments. *P < 0.05.